Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2017

Cytogenetics in Uveal Melanoma

Carol Shields, MD

Show Description +

Carol Shields, MD, reviews data from a study that examined cytogenetic mutations in patients with uveal melanoma. Dr. Shields explains the risks associated with mutations on chromosomes 3, 6, and 8, and explores how some patients are at higher risk for metastatic disease than others.

Posted: 8/13/2017

Keywords:

cytogenics

•

Uveal melanoma

Up Next

Revisiting VISTA: Nonperfusion and Aflibercept

Revisiting VISTA: Nonperfusion and Aflibercept

Charles Wykoff, MD, PhD

Açai-based Surgical Dye

Açai-based Surgical Dye

Mauricio Maia, MD, PhD

DEL MAR: Phase 2, Stage 2

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Mapping Perfusion Density

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Digitally Assisted Vitreoretinal Surgery

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Novel Technique for Steroid Injection

Novel Technique for Steroid Injection

Michael Singer, MD

Treatments for VMT

Treatments for VMT

Nathan C. Steinle, MD

Remaining Cost Effective with 'Slurry' Kenalog

Remaining Cost Effective with 'Slurry' Kenalog

Susan M. Malinowski, MD

Novel Technique for Visual Recovery Testing

Novel Technique for Visual Recovery Testing

John B. Miller, MD

Real-World Outcomes of Anti-VEGF Therapy in DME

Real-World Outcomes of Anti-VEGF Therapy in DME

Thomas A. Ciulla, MD, MBA

Intraoperative OCT in Subretinal Therapeutic Delivery

Intraoperative OCT in Subretinal Therapeutic Delivery

Lejla Vajzovic, MD

Back to All Videos

Cytogenetics in Uveal Melanoma

Carol Shields, MD

Carol Shields, MD, reviews data from a study that examined cytogenetic mutations in patients with uveal melanoma. Dr. Shields explains the risks associated with mutations on chromosomes 3, 6, and 8, and explores how some patients are at higher risk for metastatic disease than others.

Posted: 8/13/2017

Keywords:

cytogenics

•

Uveal melanoma

Please log in to leave a comment.

More From ASRS: 2017 Coverage

DEL MAR: Phase 2, Stage 2

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Mapping Perfusion Density

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2017.